CD44 and cancer: Peptides RI37 (PTX3 amino acids 200–236)30 and GI40 (PTX3 amino acids 320–359) were generated and assessed to verify the interaction interface between PTX3 and CD44 and its effect on the metastasis/invasion of cancer cells (Figure S7D).